U.S. market Closed. Opens in 3 hours 43 minutes

BHC | Bausch Health Companies Inc. Stock Fundamentals

(Stock Exchange: NYSE)
Analyzing fundamentals for BHC we got that it has weak fundamentals where Valuation is considered to be fairly valued, Profitability is unacceptably poor, Growth is bad and Health is frighteningly weak.

Valuation (52%)

Company Industry
P/E Ratio (TTM) -80.57 17.23
PEG Ratio (TTM) 0.86 -32.93
P/S Ratio (TTM) 0.32 5.23
P/B Ratio (TTM) -2.52 4.53
P/FCF Ratio (TTM) 3.26 14.91
Price to 5YR AVG Earnings Ratio -3.51 24.57
Price to 5YR AVG FCF Ratio 5.03 18.08

Profitability (10%)

Company Industry
ROA (TTM) -0.14% 4.02%
ROE (TTM) 3.27% 27.89%
Net Profit Margin (TTM) -0.40% -9.55%
ROIC 5YR AVG 3.79% 12.32%

Growth (43%)

4QTR AVG 3YR AVG 5YR AVG
EPS -330.37% 20.02% -7.42%
Revenue 2.99% 0.35% 1.03%
Net Income -337.45% 19.35% -8.77%
Cash Flow 19.96% 0.79% 18.62%

Health (14%)

Company Industry
Current Ratio (TTM) 1.19 2.51
Quick Ratio (TTM) 0.82 1.87
D/E Ratio (TTM) -18.43 -0.07
Interest Coverage (TTM) -0.88 16.86
Piotroski F-Score 4 6
Altman Z-Score N/A 4.41
LTL to 5YR AVG FCF 37.41 3.86
Shares Outstanding Growth 5YR AVG 0.85% 24.93%
An error has occurred. This application may no longer respond until reloaded. Reload 🗙